Related Experiment Video
Updated: Feb 11, 2026

A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene
Published on: April 1, 2019
Polymorphisms of Antioxidant Genes as a Target for Diabetes Management
Ozra Tabatabaei-Malazy1,2, Mehrnoosh Khodaeian2, Fatemeh Bitarafan2
1Diabetes Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Abstract:
Diabetes mellitus (DM) is one of the most important health problems with increasing prevalence worldwide. Oxidative stress, a result of imbalance between reactive oxygen species (ROS) generation and antioxidant defense mechanisms has been demonstrated as the main pathology in DM. Hyperglycemia-induced ROS productions can induce oxidative stress through four major molecular mechanisms including the polyol pathway, advanced glycation end- products formation, activation of protein kinase C isoforms, and the hexosamine pathways. In the development of type 2 DM (T2DM) and its complications, genetic and environmental factors play important roles. Therefore, the aim of this review was to focus on the assessment of single-nucleotide polymorphisms within antioxidant enzymes including superoxide dismutase, catalase, glutathione peroxidase, glutathione-S-transferase, nitric oxide synthase, and NAD(P)H oxidase and their association with T2DM. The results would be helpful in understanding the mechanisms involved in pathogenesis of disease besides discovering new treatment approaches in management of DM.
Insights
This review examines how genetic variations in antioxidant enzymes impact type 2 diabetes (T2DM) risk. Understanding these links to oxidative stress can reveal new treatment strategies for diabetes mellitus (DM).
Area of Science:
- Biochemistry
- Genetics
- Endocrinology
Background:
- Diabetes mellitus (DM) is a global health concern with rising prevalence.
- Oxidative stress, caused by an imbalance in reactive oxygen species (ROS) and antioxidant defenses, is a key factor in DM pathology.
- Hyperglycemia exacerbates oxidative stress via pathways like the polyol pathway and advanced glycation end-product formation.
Purpose of the Study:
- To review the association between single-nucleotide polymorphisms (SNPs) in antioxidant enzymes and type 2 diabetes mellitus (T2DM).
- To explore the role of genetic factors in T2DM pathogenesis and complications.
Main Methods:
- Literature review focusing on genetic polymorphisms in antioxidant enzymes.
- Analysis of studies investigating the link between SNPs in superoxide dismutase, catalase, glutathione peroxidase, glutathione-S-transferase, nitric oxide synthase, and NAD(P)H oxidase with T2DM.
Main Results:
- Genetic variations in antioxidant enzymes are implicated in the development of T2DM.
- Specific SNPs within these enzymes may alter antioxidant capacity, influencing disease susceptibility.
- This highlights the interplay between genetic predisposition and oxidative stress in T2DM.
Conclusions:
- Genetic polymorphisms in antioxidant enzymes are significant factors in T2DM pathogenesis.
- Further research into these genetic associations can inform novel therapeutic approaches for managing DM.
- Understanding these mechanisms is crucial for personalized diabetes care.
Related Concept Videos
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Single Nucleotide Polymorphisms-SNPs
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Psychoneuroimmunology: Diabetes and Cancer
Gene Flow

